Business Wire October 27, 2020
Report, which includes Washington, D.C., spotlights states implementing drug affordability review boards and details legislative landscape and legal challenges
LOS ANGELES–(BUSINESS WIRE)–Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today the release of a comprehensive survey that analyzes the status of all states’ prescription drug affordability review boards legislative initiatives. The report, titled, “State Drug Affordability Boards: A Comprehensive Review of Enacted and Pending Legislation,” found that 17 states have either authorized the implementation of prescription drug affordability review boards or commissions, or have explored their establishment through legislation.
“With drug affordability boards gaining popularity among states as they work to lower costs, our report highlights the most pressing,...
Today's Sponsors
Today's Sponsor